Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3876814rdf:typepubmed:Citationlld:pubmed
pubmed-article:3876814lifeskim:mentionsumls-concept:C0016004lld:lifeskim
pubmed-article:3876814lifeskim:mentionsumls-concept:C0019120lld:lifeskim
pubmed-article:3876814lifeskim:mentionsumls-concept:C0016709lld:lifeskim
pubmed-article:3876814lifeskim:mentionsumls-concept:C1441547lld:lifeskim
pubmed-article:3876814lifeskim:mentionsumls-concept:C1280519lld:lifeskim
pubmed-article:3876814pubmed:issue4lld:pubmed
pubmed-article:3876814pubmed:dateCreated1985-11-15lld:pubmed
pubmed-article:3876814pubmed:abstractTextFibrin glue derived from pooled human blood is an effective sealant for high-porosity vascular grafts and a valuable topical hemostatic agent in heparinized patients. Use of this agent in the United States is prohibited because of potential transmission of hepatitis B, acquired immunodeficiency syndrome, and other serologically transmitted illnesses. We have developed a cryoprecipitation technique that allows preparation of fibrin glue from single-donor fresh frozen plasma. Use of this agent presumably entails no greater risk of disease transmission than intravenous administration of single-unit fresh frozen plasma. This report describes our early clinical experience with this material. Fibrin glue was used as a sealant for porous woven Dacron tubular prostheses and cardiovascular patches in 19 patients. The fibrin glue sealant has also been employed to control bleeding from needle holes and small anastomotic tears in 22 patients. No patient in this series had a bleeding complication from a suture line or graft treated with fibrin glue. This experience indicates that like fibrin glue from pooled blood, fibrin glue from single-donor plasma is effective as a graft sealant and topical hemostatic agent. Preparation of fibrin glue from single-donor plasma is simple and economical, and may provide cardiothoracic surgeons in the United States with a widely available, valuable hemostatic adjunct.lld:pubmed
pubmed-article:3876814pubmed:languageenglld:pubmed
pubmed-article:3876814pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3876814pubmed:citationSubsetAIMlld:pubmed
pubmed-article:3876814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3876814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3876814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3876814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3876814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3876814pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3876814pubmed:statusMEDLINElld:pubmed
pubmed-article:3876814pubmed:monthOctlld:pubmed
pubmed-article:3876814pubmed:issn0003-4975lld:pubmed
pubmed-article:3876814pubmed:authorpubmed-author:ReemtsmaKKlld:pubmed
pubmed-article:3876814pubmed:authorpubmed-author:SmithC RCRlld:pubmed
pubmed-article:3876814pubmed:authorpubmed-author:RostE RERlld:pubmed
pubmed-article:3876814pubmed:authorpubmed-author:MalmJ RJRlld:pubmed
pubmed-article:3876814pubmed:authorpubmed-author:SpotnitzH MHMlld:pubmed
pubmed-article:3876814pubmed:authorpubmed-author:BowmanF OFOJrlld:pubmed
pubmed-article:3876814pubmed:authorpubmed-author:DresdaleAAlld:pubmed
pubmed-article:3876814pubmed:issnTypePrintlld:pubmed
pubmed-article:3876814pubmed:volume40lld:pubmed
pubmed-article:3876814pubmed:ownerNLMlld:pubmed
pubmed-article:3876814pubmed:authorsCompleteYlld:pubmed
pubmed-article:3876814pubmed:pagination385-7lld:pubmed
pubmed-article:3876814pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:3876814pubmed:meshHeadingpubmed-meshheading:3876814-...lld:pubmed
pubmed-article:3876814pubmed:meshHeadingpubmed-meshheading:3876814-...lld:pubmed
pubmed-article:3876814pubmed:meshHeadingpubmed-meshheading:3876814-...lld:pubmed
pubmed-article:3876814pubmed:meshHeadingpubmed-meshheading:3876814-...lld:pubmed
pubmed-article:3876814pubmed:meshHeadingpubmed-meshheading:3876814-...lld:pubmed
pubmed-article:3876814pubmed:meshHeadingpubmed-meshheading:3876814-...lld:pubmed
pubmed-article:3876814pubmed:meshHeadingpubmed-meshheading:3876814-...lld:pubmed
pubmed-article:3876814pubmed:meshHeadingpubmed-meshheading:3876814-...lld:pubmed
pubmed-article:3876814pubmed:meshHeadingpubmed-meshheading:3876814-...lld:pubmed
pubmed-article:3876814pubmed:meshHeadingpubmed-meshheading:3876814-...lld:pubmed
pubmed-article:3876814pubmed:meshHeadingpubmed-meshheading:3876814-...lld:pubmed
pubmed-article:3876814pubmed:year1985lld:pubmed
pubmed-article:3876814pubmed:articleTitleHemostatic effectiveness of fibrin glue derived from single-donor fresh frozen plasma.lld:pubmed
pubmed-article:3876814pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3876814lld:pubmed